Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Éva Katalin, Kelemen"'
Autor:
Béla Kovács, Erzsébet-Orsolya Tőkés, Éva Katalin Kelemen, Katalin Zöldi, Francisc Boda, Edit Suba, Boglárka Kovács-Deák, Tibor Casian
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 391 (2024)
Solid pharmaceutical formulations with class II active pharmaceutical ingredients (APIs) face dissolution challenges due to limited solubility, affecting in vivo behavior. Robust computational tools, via data mining, offer valuable insights into prod
Externí odkaz:
https://doaj.org/article/a40a8ca590424eeeab381cc100e1c922
Autor:
Elek Ferencz, Arnold Zöldhegyi, Éva-Katalin Kelemen, Mona Obreja, Melinda Urkon, Emese Sipos, Gergő Tóth, Imre Molnár, Zoltán-István Szabó
Publikováno v:
Journal of chromatography. A. 1682
There are several potential advantages of using experimental design-based retention modeling for chromatographic method development. Most importantly, through the model-delivered systematic understanding (Design Spaces), users can benefit from increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a24a5233e732dcd79bf2f2e44455725
https://pubmed.ncbi.nlm.nih.gov/36126559
https://pubmed.ncbi.nlm.nih.gov/36126559
Autor:
Elek Ferencz, Arnold Zöldhegyi, Éva-Katalin Kelemen, Mona Obreja, Melinda Urkon, Emese Sipos, Gergő Tóth, Imre Molnár, Zoltán -. István Szabó
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7504ec034e8b71e88f7f9e516756fb79
https://doi.org/10.2139/ssrn.4144136
https://doi.org/10.2139/ssrn.4144136
Autor:
Blanka Székely-Szentmiklósi, Előd Ernő Nagy, Boglárka Kovács-Deák, Béla Kovács, Éva Katalin Kelemen, István Székely-Szentmiklósi, Réka Molnár, Árpád Gyéresi
Publikováno v:
Acta Medica Marisiensis, Vol 65, Iss 2, Pp 55-59 (2019)
Objective: The present work offers a fast, reliable and easy UV spectrophotometric method for the assay of strontium ranelate from bulk samples and pharmaceutical dosage form. Methods: The proposed method uses 0.1% V/V trichloroacetic acid as dissolu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c340079f813d740139ce23a5edfb9eb
https://doaj.org/article/9181bfddab3344198cfb05abf1b9fd01
https://doaj.org/article/9181bfddab3344198cfb05abf1b9fd01
Autor:
Elek Ferencz, Éva-Katalin Kelemen, Zoltán-István Szabó, Emese Sipos, Mona Obreja, Sára Vida, Melinda Urkon
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 203:114203
Computer-aided ultrahigh performance liquid chromatographic (UHPLC) method development and optimization was undertaken in order to replace an underperforming European Pharmacopoeia method for the determination of albendazole and its related substance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8db9a02e53572abf61255d798eceb4
https://doi.org/10.1016/j.jpba.2021.114203
https://doi.org/10.1016/j.jpba.2021.114203
Autor:
Blanka Székely-Szentmiklósi, Ibolya Fülöp, Béla Kovács, Éva Katalin Kelemen, Boglárka Kovács-Deák, Francisc Boda, István Székely-Szentmiklósi
Publikováno v:
Acta Pharmaceutica
Volume 70
Issue 4
Acta Pharmaceutica, Vol 70, Iss 4, Pp 465-482 (2020)
Volume 70
Issue 4
Acta Pharmaceutica, Vol 70, Iss 4, Pp 465-482 (2020)
Offering a systematic and multivariate analysis of the analytical procedure, development and validation of HPLC methods using Quality by Design approach are in the limelight of current research trends. A new, experimental design-aided HPLC method for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db951cf52f15970843eb4101b028d6a
https://pubmed.ncbi.nlm.nih.gov/32412430
https://pubmed.ncbi.nlm.nih.gov/32412430
Autor:
Éva Katalin Kelemen, Mohammadhassan Foroughbakhshfasaei, Elek Ferencz, Béla Kovács, Francisc Boda, Zoltán-István Szabó, Gergő Tóth
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 177:112851
A high performance liquid chromatographic method was developed for the simultaneous determination of the related substances (R-ivabradine, dehydro-S-ivabradine, N-demethyl-S-ivabradine, ((S)-3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-triene-7-yl-methyl)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b55905201b0eb1e869b9929171d4ca3
https://doi.org/10.1016/j.jpba.2019.112851
https://doi.org/10.1016/j.jpba.2019.112851
Autor:
Éva Katalin, Kelemen1 katalin.kelemen@gedeon-richter.ro, Kelemen, L. J.1, Gyéresi, Á2, Silvia, Imre3, Mona, Obreja1
Publikováno v:
Acta Medica Marisiensis. 2012, Vol. 58 Issue 5, p301-304. 4p. 5 Graphs.